State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder (Q41197311)

28 September 2017

title

State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder (English)

1 reference

28 September 2017

1 reference

1 reference

Jonathan D Brown

1

1 reference

28 September 2017

Allison Barrett

2

1 reference

28 September 2017

Kerianne Hourihan

3

1 reference

28 September 2017

Emily Caffery

4

1 reference

28 September 2017

Henry T Ireys

5

1 reference

28 September 2017

publication date

19 March 2015

1 reference

Community Mental Health Journal

28 September 2017

published in

1 reference

28 September 2017

volume

51

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

523-534

1 reference

Changes over time and disparities in schizophrenia treatment quality

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Characteristics, healthcare utilization and costs of bipolar disorder type I patients with and without frequent psychiatric intervention in a Medicaid population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Medication Adherence and Hospitalization Among Patients With Schizophrenia Treated With Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Outpatient antipsychotic treatment and inpatient costs of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Preventive health examinations and preventive gynecological examinations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Continuity of care and health care costs among persons with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Health care utilization and costs among patients treated for bipolar disorder in an insured population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10597-015-9857-5

Changes in the quality of care for bipolar I disorder during the 1990s

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25786723

12 December 2020

inferred from PubMed ID database lookup

Medicare and Medicaid Costs for Schizophrenia Patients by Age Cohort Compared With Costs for Depression, Dementia, and Medically Ill Patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25786723

12 December 2020

inferred from PubMed ID database lookup

Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25786723

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10597-015-9857-5

1 reference

Dimensions Publication ID

28 September 2017

1027810136

0 references

Fatcat ID

release_worhpjjpmbeazctmsv7rpodeya

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/worhpjjpmbeazctmsv7rpodeya

24 November 2022

mapped directly with Wikidata item

1 reference